(MENAFN - PR Newswire) GOTHENBURG, Sweden, March 31, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B) , an innovative biotech pioneering treatments to enhance and extend life for ...
Cereno Scientific Reports Favorable Safety And Tolerability After 12 Months Of CS1 Treatment In PAH From The Expanded Access Program
